@FinMcS's saved articles

A list by Fin McSkimming

Articles that have been saved by @FinMcS

This list contains 7 articles Last updated Nov 25, 2021

This list can be subscribed to via the RSS
Find related articles using our Article recommendations
This list on Sciety

Showing page 1 of 1 pages of list content

Mitoxantrone modulates a glycosaminoglycan-spike complex to inhibit SARS-CoV-2 infection

This article's authors
1. Qi Zhang
2. Peter Radvak
3. Juhyung Lee
4. Yue Xu
5. Vivian Cao-Dao
6. Miao Xu
7. Wei Zheng
8. Catherine Z. Chen
9. Hang Xie
10. Yihong Ye
This article has 1 evaluations Latest evaluation on Oct 22, 2021 Published on Oct 18, 2021 Added on Nov 25, 2021
Discovery of Potent Triple Inhibitors of Both SARS-CoV-2 Proteases and Human Cathepsin L

This article's authors
1. Ittipat Meewan
2. Jacob Kattoula
3. Julius Y. Kattoula
4. Danielle Skinner
5. Pavla Fajtová
6. Miriam A. Giardini
7. Brendon Woodworth
8. James H. McKerrow
9. Jair Lage de Siqueira-Neto
10. Anthony J. O’Donoghue
11. Ruben Abagyan
This article has 1 evaluations Latest evaluation on Oct 23, 2021 Published on Oct 20, 2021 Added on Nov 25, 2021
Drug targeting Nsp1-ribosomal complex shows antiviral activity against SARS-CoV-2

This article's authors
1. Mohammad Afsar
2. Rohan Narayan
3. Md Noor Akhtar
4. Huma Rahil
5. Sandeep M Eswarappa
6. Shashank Tripathi
7. Tanweer Hussain
This article has 5 evaluations Latest evaluation on Mar 25, 2022 Published on Nov 3, 2021 Added on Nov 25, 2021
SARS-CoV-2 ORF8 encoded protein contains a histone mimic, disrupts chromatin regulation, and enhances replication

This article's authors
1. John Kee
2. Samuel Thudium
3. David Renner
4. Karl Glastad
5. Katherine Palozola
6. Zhen Zhang
7. Yize Li
8. Joseph Cesare
9. Yemin Lan
10. Rachel Truitt
11. Fabian L. Cardenas-Diaz
12. Darrell N. Kotton
13. Konstantinos D. Alysandratos
14. Xianwen Zhang
15. Xuping Xie
16. Pei-Yong Shi
17. Wenli Yang
18. Edward Morrisey
19. Benjamin A. Garcia
20. Shelley L. Berger
21. Susan R. Weiss
22. Erica Korb
This article has 1 evaluations Latest evaluation on Nov 19, 2021 Published on Nov 11, 2021 Added on Nov 25, 2021
The Delta variant of SARS-CoV-2 maintains high sensitivity to interferons in human lung cells

This article's authors
1. Rayhane Nchioua
2. Annika Schundner
3. Susanne Klute
4. Sabrina Noettger
5. Fabian Zech
6. Lennart Koepke
7. Alexander Graf
8. Stefan Krebs
9. Helmut Blum
10. Dorota Kmiec
11. Manfred Frick
12. Frank Kirchhoff
13. Konstantin M.J. Sparrer
This article has 1 evaluations Latest evaluation on Nov 20, 2021 Published on Nov 17, 2021 Added on Nov 25, 2021
Metformin Suppresses SARS-CoV-2 in Cell Culture

This article's authors
1. Haripriya Parthasarathy
2. Dixit Tandel
3. Abdul Hamid Siddiqui
4. Krishnan H. Harshan
This article has 1 evaluations Latest evaluation on Nov 30, 2021 Published on Jul 29, 2022 Added on Nov 25, 2021
Atazanavir is a competitive inhibitor of SARS-CoV-2 M^pro, impairing variants replication in vitro and in vivo

This article's authors
1. Otávio Augusto Chaves
2. Carolina Q. Sacramento
3. André C. Ferreira
4. Mayara Mattos
5. Natalia Fintelman-Rodrigues
6. Jairo R. Temerozo
7. Douglas Pereira Pinto
8. Gabriel P. E. da Silveira
9. Laís Bastos da Fonseca
10. Heliana Martins Pereira
11. Aluana Santana Carlos
12. Joana da Costa Pinto d’Ávila
13. João P.B. Viola
14. Robson Q. Monteiro
15. Leonardo Vazquez
16. Patrícia T. Bozza
17. Hugo Caire Castro-Faria-Neto
18. Thiago Moreno L. Souza
This article has 1 evaluations Latest evaluation on Nov 30, 2021 Published on Nov 24, 2021 Added on Nov 25, 2021

Mitoxantrone modulates a glycosaminoglycan-spike complex to inhibit SARS-CoV-2 infection

Discovery of Potent Triple Inhibitors of Both SARS-CoV-2 Proteases and Human Cathepsin L

Drug targeting Nsp1-ribosomal complex shows antiviral activity against SARS-CoV-2

SARS-CoV-2 ORF8 encoded protein contains a histone mimic, disrupts chromatin regulation, and enhances replication

The Delta variant of SARS-CoV-2 maintains high sensitivity to interferons in human lung cells

Metformin Suppresses SARS-CoV-2 in Cell Culture

Atazanavir is a competitive inhibitor of SARS-CoV-2 Mpro, impairing variants replication in vitro and in vivo

Atazanavir is a competitive inhibitor of SARS-CoV-2 M^pro, impairing variants replication in vitro and in vivo